Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
PD 169316
Cat. No.:
OB0225LY-0359
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
PD 169316 is a compound that selectively inhibits a-diol esterase (GSK-3) and is commonly used to study its role in metabolism or neuroprotection.
Synonym:
152121-53-4; PD-169316; PD169316; 4-(4-(4-Fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl)pyridine; 4-[4-(4-Fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl]pyridine; 4-(4-Fluorophenyl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1H-imidazole
CAS No.:
152121-53-4
Compound CID:
4712
Formula:
C20H13FN4O2
Formula Weight:
360.34
Specification
Relative Density:
1.345 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
PD 169316 can be used for research in the field of neurodegenerative diseases or play an important role in the study of diabetes-related mechanisms.
Library Information
Targets:
Virus protease; MAPK family
Receptors:
p38 MAPK
Pathways:
Autophagy; Microbiology/Virology; MAPK
Plate Number:
AOCL-5
Plate Location:
f4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
3.6 mg/mL; 9.98 mM
